Home > Healthcare & Medical Devices > Minimally Invasive Female Urinary Incontinence Devices Market
Minimally Invasive Female Urinary Incontinence Devices Market Size is set to increase rapidly over 2022-2028. This can be credited to the rising awareness about the advantages of minimally invasive surgery over open surgery, such as less pain, reduced bleeding, and faster recovery. The increasing prevalence of neurological diseases like multiple sclerosis will also proliferate the adoption of minimally invasive surgery for urinary incontinence, as bladder disorders are highly common in patients with MS. Urinary incontinence refers to a condition in which there is a loss of bladder control, causing accidental urine leakage. This condition affects twice as many women as men, given the impact of pregnancy, menopause, and childbirth on the bladder and other urinary organs. Minimally invasive procedures including sling surgery are common procedures designed to treat urinary stress incontinence.
Growing number of elderly people in middle- and low-income countries will foster minimally invasive female urinary incontinence devices market trends over 2022-2028. According to the WHO’s data, the proportion of the world’s population aged over 60 years will nearly double from 12% in 2015 to 22% in 2050. This factor could amplify the need for urinary incontinence surgery, given the high incidence of the disease among older adults. In addition, the rise in healthcare spending in developing economies and the deployment of cutting-edge technologies in minimally invasive surgeries will also fuel industry growth over the forecast spell.
With regards to product, the minimally invasive female urinary incontinence devices market from urinary catheters segment is expected to amass considerable gains by 2028. Growth from the segment is due to the rising incidence of spinal cord injury, and the usage advantages of the product among bed-bound patients. Based on incontinence type, the functional incontinence segment will account for a major market share over the forthcoming years. This is on account of the greater prevalence of neurological conditions like Parkinson's disease among women, which is among the main causes of functional incontinence.
Latin America minimally invasive female urinary incontinence devices market will depict a strong growth rate through 2028. This is driven by the high burden of diabetes among adults in Brazil, which can lead to a rise in incontinence as this chronic disease can affect a person’s bladder control. Furthermore, the escalating number of people with overactive bladder and the potential increase in geriatric people will also stimulate the requirement of minimally invasive surgeries to treat urinary incontinence in women across the region.
Key minimally invasive female urinary incontinence devices market players include Cogentix Medical (Laborie), Promedon, Prosurg, Covidien (Medtronic), Cook Medical, Ethicon (Johnson & Johnson), ConvaTec, Caldera Medical, C. R. Bard (BD), Karl Storz, Coloplast, Baxter, and Boston Scientific, among others. These companies are focusing on new product launches and collaborations, among other strategies to reinforce their presence in the competitive market.
COVID-19 pandemic has had a substantial impact on waiting times for elective surgery due to lockdown and other restrictions. Concerns regarding the spread of coronavirus have also resulted in delays in non-urgent and elective procedures.These aforesaid factors may have created a hindrance to the steady growth of the minimally invasive female urinary incontinence devices industry in recent months.
However, the awareness about the development of bladder symptoms among COVID-19-infected patients may aid industry recovery over the foreseeable future. According to a case series presented at the AUA (American Urological Association) 2021 Annual Meeting, the new-onset bladder symptoms can impact both men and women hospitalized with COVID-19, which could amplify the demand for female incontinence devices worldwide.
Market, by Product
Market, by Incontinence Type
Market, by End-use
The above information is provided for the following regions and countries: